{"rows":[{"id":1990,"title":"Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.","authors":"Back AL, McGregor BA, Billingsley L, Blom D, Callan G, Myers S, Guy J, Kumar S, Layer M, Levin J, Perez J, Thompson P, Salmonson K, Whinney J, Thorn LL","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1177/28314425251404460","pubmed_id":"42539893","openalex_id":"https://openalex.org/W7116873484","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539893/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Emotional Processing,Clinical Trial,Cancer Patients,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:52:05","last_checked":"2026-08-09 08:27:44","bibtex":null,"source_record_id":"PMID:42539893","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42539893/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42539893","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539893/","doi":"10.1177/28314425251404460","pmid":"42539893","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":46,"title":"Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic Review.","authors":"Cruz L, Beserra FR, Freind JMK, Rodrigues SE, Mograbi DC","journal":"Journal of clinical psychology","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1002/jclp.70167","pubmed_id":"42296474","openalex_id":"https://openalex.org/W7164838909","source_url":"https://pubmed.ncbi.nlm.nih.gov/42296474/","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Clinical Trial,Systematic Review,Review Article","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:44","bibtex":null,"source_record_id":"PMID:42296474","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42296474/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42296474","source_url":"https://pubmed.ncbi.nlm.nih.gov/42296474/","doi":"10.1002/jclp.70167","pmid":"42296474","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5875,"title":"JAMA study examines Oregon's psilocybin services model","authors":"Canady Valerie A.","journal":"Mental Health Weekly","publication_date":"2026-08-24","publication_year":2026,"doi":"10.1002/mhw.34984","pubmed_id":null,"openalex_id":"https://openalex.org/W7203871494","source_url":"https://doi.org/10.1002/mhw.34984","substance_tags":"psilocybin","topic_tags":"Clinical Trial,Safety","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-08-22 01:20:15","last_checked":"2026-08-23 01:20:19","bibtex":null,"source_record_id":"DOI:10.1002/mhw.34984","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1002/mhw.34984","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1002/mhw.34984","source_url":"https://doi.org/10.1002/mhw.34984","doi":"10.1002/mhw.34984","pmid":"","publication_date":"2026-08-24","importer_version":"2.1.3","text_redistributed":false}},{"id":3540,"title":"Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression: A Pilot Randomized Clinical Trial","authors":"Centre for Addiction and Mental Health","journal":"ClinicalTrials.gov","publication_date":"2026-08-21","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07211438","substance_tags":"psilocybin","topic_tags":"Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-08-23 01:23:20","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07211438","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07211438","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07211438","source_url":"https://clinicaltrials.gov/study/NCT07211438","doi":"","pmid":"","publication_date":"2026-08-21","importer_version":"2.1.3","text_redistributed":false}},{"id":5877,"title":"The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A Narrative Review","authors":"Clark Rachel N","journal":"Lynchburg Journal of Medical Science","publication_date":"2026-08-20","publication_year":2026,"doi":"10.63932/3067-7106.1087","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.63932/3067-7106.1087","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Addiction,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Safety","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-08-22 01:20:15","last_checked":"2026-08-23 01:20:15","bibtex":null,"source_record_id":"DOI:10.63932/3067-7106.1087","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.63932/3067-7106.1087","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.63932/3067-7106.1087","source_url":"https://doi.org/10.63932/3067-7106.1087","doi":"10.63932/3067-7106.1087","pmid":"","publication_date":"2026-08-20","importer_version":"2.1.3","text_redistributed":false}},{"id":5869,"title":"The Abuse Liability of Classic Psychedelics: A Methodological Critique and Assessment of the Quality of Evidence of Recent Studies","authors":"Michael J. Broman, Jhuma N. Acharya, Kaltum Ahmed, Stacey B. Armstrong, Alan K. Davis","journal":"Current Addiction Reports","publication_date":"2026-08-18","publication_year":2026,"doi":"10.1007/s40429-026-00774-8","pubmed_id":null,"openalex_id":"https://openalex.org/W7203711549","source_url":"https://doi.org/10.1007/s40429-026-00774-8","substance_tags":"psilocybin","topic_tags":"Clinical Trial,Review Article,Safety,Toxicity,Abuse Liability","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-20 01:20:19","last_checked":"2026-08-23 01:20:19","bibtex":null,"source_record_id":"DOI:10.1007/s40429-026-00774-8","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1007/s40429-026-00774-8","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1007/s40429-026-00774-8","source_url":"https://doi.org/10.1007/s40429-026-00774-8","doi":"10.1007/s40429-026-00774-8","pmid":"","publication_date":"2026-08-18","importer_version":"2.1.3","text_redistributed":false}},{"id":3490,"title":"A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder","authors":"COMPASS Pathways","journal":"ClinicalTrials.gov","publication_date":"2026-08-18","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07570654","substance_tags":"psilocybin","topic_tags":"PTSD,Clinical Trial,Safety","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:27","last_checked":"2026-08-23 01:23:20","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07570654","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07570654","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07570654","source_url":"https://clinicaltrials.gov/study/NCT07570654","doi":"","pmid":"","publication_date":"2026-08-18","importer_version":"2.1.3","text_redistributed":false}},{"id":5866,"title":"Assessing Canadian Policy Readiness for Psychedelic-Assisted Therapy in Cancer Care","authors":"Christopher P. Albertyn, Ron Shore, Linda E. Carlson, Erika Dyck, David Clements","journal":null,"publication_date":"2026-08-17","publication_year":2026,"doi":"10.5281/zenodo.21983116","pubmed_id":null,"openalex_id":"https://openalex.org/W7203633773","source_url":"https://doi.org/10.5281/zenodo.21983116","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Mechanism of Action,Clinical Trial,Review Article,Healthcare Workers,Safety,Toxicity","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-19 01:20:25","last_checked":"2026-08-23 01:20:19","bibtex":null,"source_record_id":"DOI:10.5281/zenodo.21983116","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.5281/zenodo.21983116","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.5281/zenodo.21983116","source_url":"https://doi.org/10.5281/zenodo.21983116","doi":"10.5281/zenodo.21983116","pmid":"","publication_date":"2026-08-17","importer_version":"2.1.3","text_redistributed":false}},{"id":5865,"title":"Psilocybin-assisted psychotherapy for substance use disorders as a complex intervention: A systematic review of efficacy, mechanisms and psychotherapeutic frameworks.","authors":"Strika-Bruneau L, Elhssaini C, Fauvel B, Kervadec E, Bezo A, Amirouche A, Benyamina A, Romeo B.","journal":"Journal of psychopharmacology (Oxford, England)","publication_date":"2026-08-17","publication_year":2026,"doi":"10.1177/02698811261473436","pubmed_id":"42609034","openalex_id":null,"source_url":"https://doi.org/10.1177/02698811261473436","substance_tags":"psilocybin","topic_tags":"Addiction,Mechanism of Action,Wellbeing,Clinical Trial,Systematic Review,Review Article,Safety,Drug Interactions","study_type":"Systematic Review","source_name":"Europe PMC","publication_status":"published","date_added":"2026-08-19 01:20:04","last_checked":"2026-08-23 01:20:15","bibtex":null,"source_record_id":"PMID:42609034","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1177/02698811261473436","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42609034","source_url":"https://doi.org/10.1177/02698811261473436","doi":"10.1177/02698811261473436","pmid":"42609034","publication_date":"2026-08-17","importer_version":"2.1.3","text_redistributed":false}},{"id":5742,"title":"An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in Life","authors":"Charles Raison","journal":"ClinicalTrials.gov","publication_date":"2026-08-17","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07719088","substance_tags":"psilocybin,psilocin","topic_tags":"Neuroplasticity,Mechanism of Action,Biomarkers,Aging,Epigenetics,Cellular Senescence,Longevity,Oxidative Stress,Wellbeing,Clinical Trial,Observational Study,Animal Study,Older Adults,Safety","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-23 01:25:56","last_checked":"2026-08-23 01:23:20","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07719088","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07719088","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07719088","source_url":"https://clinicaltrials.gov/study/NCT07719088","doi":"","pmid":"","publication_date":"2026-08-17","importer_version":"2.1.3","text_redistributed":false}},{"id":3626,"title":"The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young Adults","authors":"Region Skane","journal":"ClinicalTrials.gov","publication_date":"2026-08-14","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07169747","substance_tags":"psilocybin","topic_tags":"Anxiety,Eating Disorders,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Biomarkers,Aging,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Adolescents,Healthcare Workers,Safety,Adverse Events,Toxicity,Drug Interactions","study_type":"Randomized Controlled Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-08-21 01:27:47","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07169747","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07169747","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07169747","source_url":"https://clinicaltrials.gov/study/NCT07169747","doi":"","pmid":"","publication_date":"2026-08-14","importer_version":"2.1.3","text_redistributed":false}},{"id":3678,"title":"Role of Experience, Conscious Awareness, and Plasticity in Psilocybin's Behavioral Effects - Follow-Up Study (The RECAP 2 Study)","authors":"University of Wisconsin, Madison","journal":"ClinicalTrials.gov","publication_date":"2026-08-13","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT06692192","substance_tags":"psilocybin","topic_tags":"Neuroplasticity,Brain Imaging,Wellbeing,Emotional Processing,Clinical Trial","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-08-20 01:29:20","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT06692192","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT06692192","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06692192","source_url":"https://clinicaltrials.gov/study/NCT06692192","doi":"","pmid":"","publication_date":"2026-08-13","importer_version":"2.1.3","text_redistributed":false}},{"id":3485,"title":"PsiloStudy: A Phase 2 Single-site, Double-blind, Placebo-controlled, Randomized Clinical Trial With an Open-label Extension Phase to Examine the Safety, Subjective Experiences, Acute Effects, and Suitability of Psilocybin Combined With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD)","authors":"Nathan Brashares Sackett","journal":"ClinicalTrials.gov","publication_date":"2026-08-13","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT06853912","substance_tags":"psilocybin","topic_tags":"PTSD,Addiction,Clinical Trial,Veterans,Safety","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:27","last_checked":"2026-08-20 01:29:20","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT06853912","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT06853912","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06853912","source_url":"https://clinicaltrials.gov/study/NCT06853912","doi":"","pmid":"","publication_date":"2026-08-13","importer_version":"2.1.3","text_redistributed":false}},{"id":3440,"title":"Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder: A Double-Blind, Dose-Comparison Concurrent Control Randomized Trial","authors":"Brigham and Women's Hospital","journal":"ClinicalTrials.gov","publication_date":"2026-08-13","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07296094","substance_tags":"psilocybin","topic_tags":"Anxiety,Addiction,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Emotional Processing,Clinical Trial,Safety,Adverse Events","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:27","last_checked":"2026-08-20 01:29:20","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07296094","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07296094","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07296094","source_url":"https://clinicaltrials.gov/study/NCT07296094","doi":"","pmid":"","publication_date":"2026-08-13","importer_version":"2.1.3","text_redistributed":false}},{"id":3587,"title":"Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for Alcohol Use Disorder","authors":"NYU Langone Health","journal":"ClinicalTrials.gov","publication_date":"2026-08-12","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT06349083","substance_tags":"psilocybin","topic_tags":"Addiction,Brain Imaging,Mechanism of Action,Biomarkers,Clinical Trial","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-08-19 01:24:01","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT06349083","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT06349083","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06349083","source_url":"https://clinicaltrials.gov/study/NCT06349083","doi":"","pmid":"","publication_date":"2026-08-12","importer_version":"2.1.3","text_redistributed":false}},{"id":3581,"title":"Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality","authors":"The University of Texas Health Science Center, Houston","journal":"ClinicalTrials.gov","publication_date":"2026-08-12","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT06706232","substance_tags":"psilocybin","topic_tags":"Depression,Clinical Trial,Safety","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-08-19 01:24:01","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT06706232","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT06706232","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06706232","source_url":"https://clinicaltrials.gov/study/NCT06706232","doi":"","pmid":"","publication_date":"2026-08-12","importer_version":"2.1.3","text_redistributed":false}},{"id":3574,"title":"Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring Opioids","authors":"Roswell Park Cancer Institute","journal":"ClinicalTrials.gov","publication_date":"2026-08-12","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT06827054","substance_tags":"psilocybin","topic_tags":"Addiction,End-of-Life Distress,Chronic Pain,Brain Imaging,Mechanism of Action,Aging,Spirituality,Clinical Trial,Cancer Patients,Safety,Toxicity,Inflammation","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:28","last_checked":"2026-08-19 01:24:01","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT06827054","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT06827054","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06827054","source_url":"https://clinicaltrials.gov/study/NCT06827054","doi":"","pmid":"","publication_date":"2026-08-12","importer_version":"2.1.3","text_redistributed":false}},{"id":3426,"title":"A Phase 2a, Placebo-Controlled Randomized, Double-Blind Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder","authors":"Claudio N Soares","journal":"ClinicalTrials.gov","publication_date":"2026-08-12","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT06969170","substance_tags":"psilocybin","topic_tags":"Anxiety,Brain Imaging,Clinical Trial,Healthcare Workers,Safety","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:27","last_checked":"2026-08-19 01:24:01","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT06969170","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT06969170","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT06969170","source_url":"https://clinicaltrials.gov/study/NCT06969170","doi":"","pmid":"","publication_date":"2026-08-12","importer_version":"2.1.3","text_redistributed":false}},{"id":5858,"title":"Psychedelic Therapy for Depression","authors":"Saanvi Gutta","journal":null,"publication_date":"2026-08-11","publication_year":2026,"doi":"10.5281/zenodo.21893916","pubmed_id":null,"openalex_id":"https://openalex.org/W7202215062","source_url":"https://doi.org/10.5281/zenodo.21893916","substance_tags":"psilocybin","topic_tags":"Depression,Chronic Pain,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Toxicity","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-13 01:20:27","last_checked":"2026-08-18 01:20:14","bibtex":null,"source_record_id":"DOI:10.5281/zenodo.21893916","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.5281/zenodo.21893916","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.5281/zenodo.21893916","source_url":"https://doi.org/10.5281/zenodo.21893916","doi":"10.5281/zenodo.21893916","pmid":"","publication_date":"2026-08-11","importer_version":"2.1.3","text_redistributed":false}},{"id":5852,"title":"Psilocybin Recovery Intervention for Stopping Methamphetamine Use","authors":"Nicky Mehtani, MD, MPH","journal":"ClinicalTrials.gov","publication_date":"2026-08-11","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07756736","substance_tags":"psilocybin","topic_tags":"Clinical Trial","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-08-12 01:27:30","last_checked":"2026-08-18 01:24:17","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07756736","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07756736","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07756736","source_url":"https://clinicaltrials.gov/study/NCT07756736","doi":"","pmid":"","publication_date":"2026-08-11","importer_version":"2.1.3","text_redistributed":false}}],"total":980,"page":1,"per_page":20,"pages":49,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":"Clinical Trial","study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newest","page":1,"per_page":"20"}}